Dlx5	O
and	O
mef2	O
regulate	O
a	O
novel	O
runx2	O
enhancer	O
for	O
osteoblast	S-TISSUE
-	O
specific	O
expression	O
.	O


Runx2	O
is	O
essential	O
for	O
osteoblast	S-TISSUE
differentiation	O
and	O
chondrocyte	S-TISSUE
maturation	O
.	O


The	O
expression	O
of	O
Runx2	O
is	O
the	O
first	O
requisite	O
step	O
for	O
the	O
lineage	O
determination	O
from	O
mesenchymal	B-TISSUE
stem	I-TISSUE
cells	E-TISSUE
to	O
osteoblasts	S-TISSUE
.	O


Although	O
the	O
transcript	O
from	O
Runx2	O
distal	O
promoter	O
is	O
majorly	O
expressed	O
in	O
osteoblasts	S-TISSUE
,	O
the	O
promoter	O
failed	O
to	O
direct	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
expression	O
to	O
osteoblasts	S-TISSUE
.	O


To	O
find	O
the	O
regulatory	O
region	O
,	O
we	O
generated	O
GFP	O
reporter	O
mice	O
driven	O
by	O
a	O
bacterial	O
artificial	O
chromosome	O
(	O
BAC	O
)	O
of	O
Runx2	O
locus	O
,	O
and	O
succeeded	O
in	O
the	O
reproduction	O
of	O
endogenous	O
Runx2	O
expression	O
.	O


By	O
serially	O
deleting	O
it	O
,	O
we	O
identified	O
a	O
343	O
-	O
bp	O
enhancer	O
,	O
which	O
directed	O
GFP	O
expression	O
specifically	O
to	O
osteoblasts	S-TISSUE
,	O
about	O
30	O
kb	O
upstream	O
of	O
the	O
distal	O
promoter	O
.	O


The	O
sequence	O
of	O
the	O
343	O
-	O
bp	O
enhancer	O
was	O
highly	O
conserved	O
among	O
mouse	O
,	O
human	O
,	O
dog	O
,	O
horse	O
,	O
opossum	O
,	O
and	O
chicken	O
.	O


Dlx5	O
,	O
Mef2c	O
,	O
Tcf7	O
,	O
Ctnnb1	O
,	O
Sp7	O
,	O
Smad1	O
,	O
and	O
Sox6	O
,	O
which	O
localized	O
on	O
the	O
enhancer	O
region	O
in	O
primary	O
osteoblasts	S-TISSUE
,	O
synergistically	O
upregulated	O
the	O
enhancer	O
activity	O
,	O
whereas	O
Msx2	O
downregulated	O
the	O
activity	O
in	O
mouse	O
osteoblastic	O
MC3T3	B-TISSUE
-	I-TISSUE
E1	I-TISSUE
cells	E-TISSUE
.	O


Msx2	O
was	O
predominantly	O
bound	O
to	O
the	O
enhancer	O
in	O
mouse	O
multipotent	O
mesenchymal	B-TISSUE
C3H10T1	I-TISSUE
/	I-TISSUE
2	I-TISSUE
cells	E-TISSUE
,	O
whereas	O
Dlx5	O
was	O
predominantly	O
bound	O
to	O
the	O
enhancer	O
in	O
MC3T3	B-TISSUE
-	I-TISSUE
E1	I-TISSUE
cells	E-TISSUE
.	O


Dlx5	O
and	O
Mef2	O
directly	O
bound	O
to	O
the	O
enhancer	O
,	O
and	O
the	O
binding	O
sites	O
were	O
required	O
for	O
the	O
osteoblast	S-TISSUE
-	O
specific	O
expression	O
in	O
mice	O
,	O
whereas	O
the	O
other	O
factors	O
bound	O
to	O
the	O
enhancer	O
by	O
protein	O
-	O
protein	O
interaction	O
.	O


The	O
enhancer	O
was	O
characterized	O
by	O
the	O
presence	O
of	O
the	O
histone	O
variant	O
H2A	O
.	O
Z	O
,	O
the	O
enrichment	O
of	O
histone	O
H3	O
mono	O
-	O
and	O
dimethylated	O
at	O
Lys4	O
and	O
acetylated	O
at	O
Lys18	O
and	O
Lys27	O
,	O
but	O
the	O
depletion	O
of	O
histone	O
H3	O
trimethylated	O
at	O
Lys4	O
in	O
primary	O
osteoblasts	S-TISSUE
.	O


These	O
findings	O
indicated	O
that	O
the	O
enhancer	O
,	O
which	O
had	O
typical	O
histone	O
modifications	O
for	O
enhancers	O
,	O
contains	O
sufficient	O
elements	O
to	O
direct	O
Runx2	O
expression	O
to	O
osteoblasts	S-TISSUE
,	O
and	O
that	O
Dlx5	O
and	O
Mef2	O
,	O
which	O
formed	O
an	O
enhanceosome	O
with	O
Tcf7	O
,	O
Ctnnb1	O
,	O
Sp7	O
,	O
Smad1	O
,	O
and	O
Sox6	O
,	O
play	O
an	O
essential	O
role	O
in	O
the	O
osteoblast	S-TISSUE
-	O
specific	O
activation	O
of	O
the	O
enhancer	O
.	O


2014	O
American	O
Society	O
for	O
Bone	O
and	O
Mineral	O
Research	O
.	O
